A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Beckman Symposium Bookmark and Share

The 24th Beckman Symposium - New Horizons on Oncogenesis

Date
Friday, November 14, 2014
8:45 a.m. to 5:30 p.m.

Location
City of Hope
Cooper Auditorium
1500 E. Duarte Road
Duarte, CA 91010-3000

Overview
The 24th Beckman Symposium to be held at Beckman Research Institute of City of Hope. Supported by funds from the Beckman Endowment, the Beckman Symposia are arranged annually by the research staff organization of City of Hope.
 
 
2014 Speaker List:
 
Joe Gray, Ph.D.,
Knight Cancer Institute, University of Oregon Health and Science University
 
Edward T.H. Yeh, M.D.,
University of Texas MD Anderson Cancer Center
 
Iannis Aifantis, Ph.D.,
Howard Hughes Medical Institute and NYU School of Medicine
 
Valerie Weaver, Ph.D.,
University of California, San Francisco
 
Channing Der, Ph.D.,
Lineberger Comprehensive Cancer Center,   University of North Carolina, Chapel Hill
 
Dafna Bar-Sagi, Ph.D.,
NYU Langone Medical Center
 
David Cheresh, Ph.D.,
Moores Cancer Center, University of California,  San Diego

 

In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the program coordinator listed above prior to the symposium. This advance notification will help us serve you better.

 

2014 Symposium Program

8:15 to 8:45 a.m.
Registration
 
8:50 to 9:00 a.m.
Welcome, Steven Rosen, M.D., Provost, City of Hope
 
9:00 to 10:00 a.m.
Spatial Systems Biology of Cancer
Joe Gray, Ph.D., Knight Cancer Institute, University of Oregon Health and Science University
 
10:00 to 10:15 a.m.
Break
 
10:15 to 11:15 a.m.
Doxorubicin-induced Cardiotoxicity: SUMO, Ubiquitin, and Topoisomerase 2b
Edward T.H. Yeh, M.D., University of Texas MD Anderson Cancer Center
 
11:15 a.m. to 12:15 p.m.
Epigenetic Regulation of Acute Leukemia Initiation and Progression Iannis Aifantis, Ph.D., Howard Hughes Medical Institute and NYU School of Medicine
 
12:15 to 1:15 p.m.
Lunch
 
1:15 to 2:15 p.m.
Tissue Force, Tumor Progression and Treatment
Valerie Weaver, Ph.D., University of California, San Francisco
 
2:15 to 3:15 p.m.
Drugging the Undruggable Ras: Mission Possible?
Channing Der, Ph.D., Lineberger Comprehensive Cancer Center,   University of North Carolina, Chapel Hill
 
3:15 to 3:30 p.m.
Break
 
3:30 to 4:30 p.m.
Oncogenic Ras Signaling: From Biology to Therapeutics
Dafna Bar-Sagi, Ph.D., NYU Langone Medical Center
 
4:30 to 5:30 p.m.
A β3 Integrin-KRAS-RalB Complex Drives Tumor Stemness and Resistance to EGFR Inhibition
David Cheresh, Ph.D., Moores Cancer Center, University of California,  San Diego

Beckman Symposium

The 24th Beckman Symposium - New Horizons on Oncogenesis

Date
Friday, November 14, 2014
8:45 a.m. to 5:30 p.m.

Location
City of Hope
Cooper Auditorium
1500 E. Duarte Road
Duarte, CA 91010-3000

Overview
The 24th Beckman Symposium to be held at Beckman Research Institute of City of Hope. Supported by funds from the Beckman Endowment, the Beckman Symposia are arranged annually by the research staff organization of City of Hope.
 
 
2014 Speaker List:
 
Joe Gray, Ph.D.,
Knight Cancer Institute, University of Oregon Health and Science University
 
Edward T.H. Yeh, M.D.,
University of Texas MD Anderson Cancer Center
 
Iannis Aifantis, Ph.D.,
Howard Hughes Medical Institute and NYU School of Medicine
 
Valerie Weaver, Ph.D.,
University of California, San Francisco
 
Channing Der, Ph.D.,
Lineberger Comprehensive Cancer Center,   University of North Carolina, Chapel Hill
 
Dafna Bar-Sagi, Ph.D.,
NYU Langone Medical Center
 
David Cheresh, Ph.D.,
Moores Cancer Center, University of California,  San Diego

 

In compliance with the Americans with Disabilities Act, all reasonable efforts will be made to accommodate persons with disabilities at the meeting. If you have any special dietary or accommodation needs, please notify the program coordinator listed above prior to the symposium. This advance notification will help us serve you better.

 

Symposium Program

2014 Symposium Program

8:15 to 8:45 a.m.
Registration
 
8:50 to 9:00 a.m.
Welcome, Steven Rosen, M.D., Provost, City of Hope
 
9:00 to 10:00 a.m.
Spatial Systems Biology of Cancer
Joe Gray, Ph.D., Knight Cancer Institute, University of Oregon Health and Science University
 
10:00 to 10:15 a.m.
Break
 
10:15 to 11:15 a.m.
Doxorubicin-induced Cardiotoxicity: SUMO, Ubiquitin, and Topoisomerase 2b
Edward T.H. Yeh, M.D., University of Texas MD Anderson Cancer Center
 
11:15 a.m. to 12:15 p.m.
Epigenetic Regulation of Acute Leukemia Initiation and Progression Iannis Aifantis, Ph.D., Howard Hughes Medical Institute and NYU School of Medicine
 
12:15 to 1:15 p.m.
Lunch
 
1:15 to 2:15 p.m.
Tissue Force, Tumor Progression and Treatment
Valerie Weaver, Ph.D., University of California, San Francisco
 
2:15 to 3:15 p.m.
Drugging the Undruggable Ras: Mission Possible?
Channing Der, Ph.D., Lineberger Comprehensive Cancer Center,   University of North Carolina, Chapel Hill
 
3:15 to 3:30 p.m.
Break
 
3:30 to 4:30 p.m.
Oncogenic Ras Signaling: From Biology to Therapeutics
Dafna Bar-Sagi, Ph.D., NYU Langone Medical Center
 
4:30 to 5:30 p.m.
A β3 Integrin-KRAS-RalB Complex Drives Tumor Stemness and Resistance to EGFR Inhibition
David Cheresh, Ph.D., Moores Cancer Center, University of California,  San Diego
Research Overview
Research pioneered at City of Hope has improved the lives of men, women and children throughout the world.
 
Beckman Research Institute

Beckman Research Institute of City of Hope is internationally  recognized for its innovative translational biomedical research.
 

Comprehensive Cancer Center
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and education.

Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Technology & Licensing
The Center for Applied Technology Development offers broad expertise in
technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 



NEWS & UPDATES
  • Joselyn Miller received a lifesaving bone marrow transplant at City of Hope two years ago. Here, she reflects on her gratitude as a bone marrow recipient and on giving back. By Joselyn Miller thank•ful adjective  \ˈthaŋk-fəl\ :  conscious of benefit received :  glad that something has happened or not happened, ...
  • When it comes to cancer, your family history may provide more questions than answers: How do my genes increase my risk for cancer? No one in my family has had cancer; does that mean I won’t get cancer? What cancers are common in certain populations and ethnicities? City of Hope experts have some guidance. “Your...
  • The body’s immune system is usually adept at attacking outside invaders such as bacteria and viruses. But because cancer originates from the body’s own cells, the immune system can fail to see it as foreign. As a result, the body’s most powerful ally can remain largely idle against cancer as the disease progres...
  • On Jan. 1, 2015, five City of Hope patients who have journeyed through cancer will welcome the new year with their loved ones atop City of Hope’s Tournament of Roses Parade float. The theme of the float is “Made Possible by HOPE.” The theme of the parade is “Inspiring Stories.” Her...
  • Are you thinking about switching from traditional cigarettes to e-cigarettes for the Great American Smokeout? Are you thinking that might be a better option than the traditional quit-smoking route? Think again. For lung expert Brian Tiep, M.D., the dislike and distrust he feels for e-cigs comes down to this: Th...
  • Hematologist Robert Chen, M.D., is boosting scientific discovery at City of Hope and, by extension, across the nation. Just ask the National Cancer Institute. The institution recently awarded Chen the much-sought-after Clinical Investigator Team Leadership Award for boosting scientific discovery at City of Hope...
  • Great strides have been made in treating cancer – including lung cancer – but by the time people show symptoms of the disease, the cancer has usually advanced. That’s because, at early stages, lung cancer has no symptoms. Only recently has lung cancer screening become an option. (Read more about the risks...
  • Identifying cures for currently incurable diseases and providing patients with safe, fast and potentially lifesaving treatments is the focus of City of Hope’s new Alpha Clinic for Cell Therapy and Innovation (ACT-I). The clinic is funded by an $8 million, five-year grant from the California Institute for Regene...
  • Cancer is a couple’s disease. It affects not just the person diagnosed, but his or her partner as well. It also affects the ability of both people to communicate effectively. The Couples Coping with Cancer Together program at City of Hope teaches couples how to communicate and solve problems as a unit. He...
  • Chemotherapy drugs work by either killing cancer cells or by stopping them from multiplying, that is, dividing. Some of the more powerful drugs used to treat cancer do their job by interfering with the cancer cells’ DNA and RNA growth, preventing them from copying themselves and dividing. Such drugs, however, l...
  • During October, everything seems to turn pink – clothing, the NFL logo, tape dispensers, boxing gloves, blenders, soup cans, you name it – in order to raise awareness for what many believe is the most dangerous cancer that affects women: breast cancer. But, in addition to thinking pink, women should...
  • In February 2003, when she was only 16 months old, Maya Gallardo was diagnosed with acute myelogenous leukemia (AML) and, to make matters much worse, pneumonia. The pneumonia complicated what was already destined to be grueling treatment regimen. To assess the extent of her illness, Maya had to endure a spinal ...
  • Former smokers age 55 to 74 who rely on Medicare for health care services have just received a long-hoped-for announcement. Under a proposed decision from the Centers for Medicare and Medicaid Services, they’ll now have access to lung cancer screening with a low-dose CT scan. The proposed decision, announ...
  • City of Hope has a longstanding commitment to combating diabetes, a leading national and global health threat. Already, it’s scored some successes, from research that led to the development of synthetic human insulin – still used by millions of patients – to potentially lifesaving islet cell transplants. Diabet...
  • Dee Hunt never smoked. Neither did her five sisters and brothers. They didn’t have exposure to radon or asbestos, either. That didn’t prevent every one of them from being diagnosed with lung cancer. Their parents were smokers, but they’d all left home more than 30 years before any of them were diagn...